Trial Review

Technical difficulties have been reported by some users of the search function and is being investigated by technical staff. Thank you for your patience and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT05866770




Registration number
NCT05866770
Ethics application status
Date submitted
10/05/2023
Date registered
19/05/2023
Date last updated
4/10/2023

Titles & IDs
Public title
A Study Evaluating the Application of Hearing Aid Technologies to Signal Processing for Adult Cochlear Implant Recipients
Scientific title
A Feasibility, Prospective, Multi-centre, Repeated Measures Investigation Evaluating the Application of Hearing Aid Technologies to Signal Processing for Adult Cochlear Implant Recipients
Secondary ID [1] 0 0
AI5837
Universal Trial Number (UTN)
Trial acronym
HATSI-MB
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Hearing Loss 0 0
Condition category
Condition code
Ear 0 0 0 0
Deafness

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - U8
Treatment: Devices - N8 sound processor

Other: U8 then N8 - Participants in this arm receive U8 followed by N8

Other: N8 then U8 - Participants in this arm receive N8 followed by U8


Treatment: Devices: U8
The U8 Research System

Treatment: Devices: N8 sound processor
Nucleus 8 sound processor
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percent correct monosyllabic word scores.
Timepoint [1] 0 0
3 months
Primary outcome [2] 0 0
Adaptive sentence in noise scores (AuSTIN)
Timepoint [2] 0 0
3 months

Eligibility
Key inclusion criteria
- Eighteen years of age or older

- User of CI600, CI500 or CI24RE implant

- At least 3 months experience with a TGA approved Nucleus cochlear implant in at least
one ear

- Fluent speaker of English

- A word speech recognition score of 20% or more when using the cochlear implant alone*

- Willing and able to provide written informed consent *This can be based on clinical
data if collected within the last 12 months
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Exclusion criteria:

- Unable or unwilling to comply with the requirements of the clinical investigation as
determined by the Investigator.

- Investigator site personnel directly affiliated with this study and/or their immediate
families: immediate family is defined as a spouse, parent, child, or sibling

- Cochlear employees or employees of Contract Research Organizations or contractors
engaged by Cochlear for the purposes of this investigation.

- Current participation, or participation in another interventional clinical study/trial
in the past 30 days, involving an investigational drug or device. (Unless the other
investigation was/is a Cochlear sponsored investigation and determined by the
investigator or Sponsor to not impact this investigation.

Study design
Purpose of the study
Other
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
11/09/2023
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
30/06/2026
Actual
Sample size
Target
150
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
MelbourneNSW,VIC
Recruitment hospital [1] 0 0
Cochlear Melbourne - Melbourne E.
Recruitment hospital [2] 0 0
Cochlear Macquarie - Sydney
Recruitment hospital [3] 0 0
HEARnet Clinical Studies - Carlton
Recruitment postcode(s) [1] 0 0
3002 - Melbourne E.
Recruitment postcode(s) [2] 0 0
2113 - Sydney
Recruitment postcode(s) [3] 0 0
3053 - Carlton

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Cochlear
Address
Country
Other collaborator category [1] 0 0
Commercial sector/Industry
Name [1] 0 0
Avania
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
A feasibility, prospective, multi-centre, repeated measures investigation evaluating the
application of hearing aid technologies to signal processing for adult cochlear implant
recipients
Trial website
https://clinicaltrials.gov/ct2/show/NCT05866770
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Komal Arora
Address 0 0
Country 0 0
Phone 0 0
+61 432 218 588
Fax 0 0
Email 0 0
karora@cochlear.com
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT05866770